Heliant Ventures
10
4M
7
1.11
0.30
2
- Stages of investment
- Areas of investment
Summary
In 2012 was created Heliant Ventures, which is appeared as VC. The fund was located in Asia if to be more exact in Hong Kong. The leading representative office of defined VC is situated in the Hong Kong.
The current fund was established by Benjamin Weiss. The overall number of key employees were 1.
The higher amount of exits for fund were in 2019. The high activity for fund was in 2012. Comparing to the other companies, this Heliant Ventures performs on 9 percentage points less the average number of lead investments. The common things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Israel. Among the most successful fund investment fields, there are Mechanical Design, Mobile. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Geneformics, Sanguine, SP Nano.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Heliant Ventures, startups are often financed by iVentures Asia Ltd, iNetworks 360, Docor International Management. The meaningful sponsors for the fund in investment in the same round are iVentures Asia Ltd, iNetworks 360, Docor International Management. In the next rounds fund is usually obtained by iVentures Asia Ltd, Docor International Management, Consolidated Investment Group.
Investments analytics
Analytics
- Total investments
- 10
- Lead investments
- 0
- Exits
- 2
- Rounds per year
- 1.11
- Follow on index
- 0.30
- Investments by industry
- Software (6)
- Hardware (4)
- Manufacturing (4)
- Biotechnology (3)
- Mobile (2) Show 10 more
- Investments by region
-
- Israel (6)
- United States (3)
- Kenya (1)
- Peak activity year
- 2012
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Avg. valuation at time of investment
- 30M
- Group Appearance index
- 0.80
- Avg. company exit year
- 6
- Avg. multiplicator
- 4.35
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Sanguine | 23 Feb 2013 | Biotechnology, Health Care, Clinical Trials | Seed | 2M | United States, California, Los Angeles |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.